Financhill
Buy
68

BOEUF Quote, Financials, Valuation and Earnings

Last price:
$20.12
Seasonality move :
24.18%
Day range:
$20.12 - $20.12
52-week range:
$19.81 - $35.00
Dividend yield:
0%
P/E ratio:
89.03x
P/S ratio:
12.13x
P/B ratio:
14.91x
Volume:
--
Avg. volume:
198
1-year change:
-37.67%
Market cap:
$1.3B
Revenue:
$85M
EPS (TTM):
$0.23

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, BONESUPPORT HOLDING AB has -- downside to fair value with a price target of -- per share.

BOEUF vs. S&P 500

  • Over the past 5 trading days, BONESUPPORT HOLDING AB has underperformed the S&P 500 by -2.62% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • BONESUPPORT HOLDING AB does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • BONESUPPORT HOLDING AB has grown year-over-year revenues for 21 quarters straight. In the most recent quarter BONESUPPORT HOLDING AB reported revenues of $30.9M.

Earnings Growth

  • BONESUPPORT HOLDING AB has grown year-over-year earnings for 2 quarters straight. In the most recent quarter BONESUPPORT HOLDING AB reported earnings per share of $0.05.
Enterprise value:
1.3B
EV / Invested capital:
14.28x
Price / LTM sales:
12.13x
EV / EBIT:
53.47x
EV / Revenue:
11.61x
PEG ratio (5yr expected):
1.19x
EV / Free cash flow:
53.86x
Price / Operating cash flow:
56.27x
Enterprise value / EBITDA:
51.58x
Gross Profit (TTM):
$102.6M
Return On Assets:
16.61%
Net Income Margin (TTM):
13.63%
Return On Equity:
20%
Return On Invested Capital:
19.66%
Operating Margin:
24.16%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $49M $77.3M $110.8M $22.8M $30.9M
Gross Profit $44.8M $71.4M $102.6M $21.2M $28.7M
Operating Income $173.5K $10.1M $24.1M $4.5M $7.5M
EBITDA $1M $11M $24.9M $4.7M $7.7M
Diluted EPS $0.30 $0.13 $0.23 $0.04 $0.05
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $36.5M $30.4M $34.3M $50.5M $81.7M
Total Assets $39.2M $33.3M $58.1M $76.8M $106.9M
Current Liabilities $5.9M $6.5M $8.5M $10.6M $17.3M
Total Liabilities $6.6M $7.8M $9.3M $11.5M $18M
Total Equity $32.6M $25.5M $48.8M $65.3M $88.9M
Total Debt $1.3M $1.7M $1.2M $1.5M $1.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$3.5M $651.9K $24.4M $4.1M $7.6M
Cash From Investing -$320.1K -$811K -$631.3K -$79.9K -$174.5K
Cash From Financing -$820.6K -$525.7K -$663.1K -$86.5K -$208.9K
Free Cash Flow -$3.8M -$138.4K $23.9M $4M $7.5M
BOEUF
Sector
Market Cap
$1.3B
$28.5M
Price % of 52-Week High
57.49%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-0%
-1.33%
1-Year Price Total Return
-37.67%
-20.32%
Beta (5-Year)
0.680
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $20.30
200-day SMA
Sell
Level $29.29
Bollinger Bands (100)
Sell
Level 23.72 - 33.68
Chaikin Money Flow
Sell
Level -12.7K
20-day SMA
Sell
Level $20.59
Relative Strength Index (RSI14)
Sell
Level 27.62
ADX Line
Sell
Level 60.3
Williams %R
Buy
Level -80.6854
50-day SMA
Sell
Level $24.69
MACD (12, 26)
Sell
Level -1.27
25-day Aroon Oscillator
Sell
Level -68
On Balance Volume
Sell
Level -28.4K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (98.8357)
Buy
CA Score (Annual)
Level (2.2489)
Sell
Beneish M-Score (Annual)
Level (-1.6697)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.2336)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Stock Forecast FAQ

In the current month, BOEUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BOEUF average analyst price target in the past 3 months is --.

  • Where Will BONESUPPORT HOLDING AB Stock Be In 1 Year?

    According to analysts, the consensus estimate is that BONESUPPORT HOLDING AB share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About BONESUPPORT HOLDING AB?

    Analysts are divided on their view about BONESUPPORT HOLDING AB share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that BONESUPPORT HOLDING AB is a Sell and believe this share price will rise from its current level to --.

  • What Is BONESUPPORT HOLDING AB's Price Target?

    The price target for BONESUPPORT HOLDING AB over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is BOEUF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for BONESUPPORT HOLDING AB is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of BOEUF?

    You can purchase shares of BONESUPPORT HOLDING AB via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase BONESUPPORT HOLDING AB shares.

  • What Is The BONESUPPORT HOLDING AB Share Price Today?

    BONESUPPORT HOLDING AB was last trading at $20.12 per share. This represents the most recent stock quote for BONESUPPORT HOLDING AB. Yesterday, BONESUPPORT HOLDING AB closed at $20.12 per share.

  • How To Buy BONESUPPORT HOLDING AB Stock Online?

    In order to purchase BONESUPPORT HOLDING AB stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 60.69% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 7.84% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock